Kamada (KMDA) Exchange Rate Effect (2013 - 2026)
Kamada's (KMDA) quarterly Exchange Rate Effect came in at -$202000.0 in Q1 2026, down 349.38% YoY from $81000.0 in Q1 2025, and down 44.29% on a QoQ basis from -$140000.0 in Q4 2025.
Kamada (KMDA) Exchange Rate Effect (2013 - 2026) Analysis & Trends
Kamada (KMDA) has 14 years of Exchange Rate Effect data on file, last reported at -$202000.0 in Q1 2026.
- Quarterly Exchange Rate Effect fell 349.38% year-over-year to -$202000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$556000.0 (down 2317.39% YoY) and the FY2025 annual result came in at -$273000.0, down 82.0% from the prior year.
- Exchange Rate Effect slipped to -$202000.0 in Q1 2026, from -$140000.0 in the prior quarter.
- In the past five years, Exchange Rate Effect ranged from a high of $482000.0 in Q4 2023 to a low of -$332000.0 in Q4 2024.
- A 5-year average of $26140.7 and a median of -$296.0 in 2022 frame the typical range for Exchange Rate Effect.
- Annual changes were most pronounced in 2023 — Exchange Rate Effect jumped 110910.81% — and 2024, when it plunged 14643.59%.
- Tracing KMDA's Exchange Rate Effect over 5 years: stood at $112000.0 in 2022, then surged by 330.36% to $482000.0 in 2023, then sank by 168.88% to -$332000.0 in 2024, then jumped by 57.83% to -$140000.0 in 2025, then plunged by 44.29% to -$202000.0 in 2026.
- The last three Exchange Rate Effect figures came in at -$202000.0 (Q1 2026), -$140000.0 (Q4 2025), and -$61000.0 (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Exchange Rate Effect (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 44.07 Bn | 43.10 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.42 Bn | 39.76 Bn | 2.15 Bn | -5.00 Mn |
| 3 | Zoetis | 31.86 Bn | 30.18 Bn | 1.05 Bn | -7.00 Mn |
| 4 | Takeda Pharmaceutical | 28.77 Bn | 22.98 Bn | 5.10 Bn | 39.87 Mn |
| 5 | United Therapeutics | 22.29 Bn | 19.63 Bn | 683.80 Mn | - |
| 6 | Viatris | 18.78 Bn | 17.89 Bn | 1.46 Bn | -3.30 Mn |
| 7 | Neurocrine Biosciences | 15.66 Bn | 15.27 Bn | 935.80 Mn | - |
| 8 | Elanco Animal Health | 11.91 Bn | 11.38 Bn | 798.00 Mn | 9.00 Mn |
| 9 | Dr Reddys Laboratories | 10.16 Bn | 10.00 Bn | - | - |
| 10 | Kamada | 458.29 Mn | 428.82 Mn | 22.47 Mn | 21,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 21,000.00 |
| Jun 30, 2026 | 21,000.00 |
| Mar 31, 2026 | -202,000.00 |
| Mar 31, 2026 | -202,000.00 |
| Dec 31, 2025 | -140,000.00 |
| Dec 31, 2025 | -140,000.00 |
| Sep 30, 2025 | -61,000.00 |
| Sep 30, 2025 | -61,000.00 |
| Jun 30, 2025 | -153,000.00 |
| Jun 30, 2025 | -153,000.00 |
| Mar 31, 2025 | 81,000.00 |
| Mar 31, 2025 | 81,000.00 |
| Dec 31, 2024 | -332,000.00 |
| Dec 31, 2024 | -332,000.00 |
| Sep 30, 2024 | 151,000.00 |
| Sep 30, 2024 | 151,000.00 |
| Jun 30, 2024 | 77,000.00 |
| Jun 30, 2024 | 77,000.00 |
| Mar 31, 2024 | -46,000.00 |
| Mar 31, 2024 | -46,000.00 |